DIVISLAB
Divi's Laboratories Limited
If management delivers what it guided
arithmetic on filed guidance and past valuations · not a price target
DIVISLAB
FY26 → FY27 · 1 year of guidance · ~0.7 years from today₹8,056 today
BEAR
₹3,778
-53%
5.8% a year · 36.9x exit
BASE
₹5,497
-32%
10% a year · 51.7x exit
BULL
₹6,934
-14%
13.6% a year · 63.1x exit
Where the market has priced it
16x83x today — outside the range67x
management named no year; shown one year out
- the guided figure reached earnings through a low-confidence bridge
- at 83x its FY26 earnings the stock already trades above the top of its own ten-year range (63x)
- this company's own median multiple sits 82% above its filed-industry peers; the scenario uses its own
How these numbers are produced
| Earnings base | FY26 fiscal year EPS ₹96.73 (screener) |
|---|---|
| Guided growth | 10% a year, said on the call of 29-May-2026 · transcript |
| Read across as | operating: unlabelled growth figure, read as revenue — low confidence |
| Delivery calibration | 0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings |
| Exit multiple | 36.92x / 51.66x / 63.11x, this company’s own p20 / median / p80 across 10 filed years |
| Filed-industry peers | median 28.43x across 38 peers — the cross-check, not the input |
| Arithmetic | base EPS × (1 + guided growth × delivery)1 × exit multiple |
Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.
What management said
from NSE earnings-call filings · extracted, not interpreted
generic growth 10%
Now coming to the future outlook, we would say that as historically that we always look for a double-digit growth in our revenues, and that's what we would also say today.
Call 29-May-2026 · bridge confidence low · transcript PDF